Zydus Pharma`s Generics Paliperidone Receives Approval in US
08 Oct 2024 //
FDA
Alembic Pharma gets USFDA nod for schizophrenia Drug
28 Sep 2024 //
ECOMONICTIMES
Alembic`s Generics Paliperidone Receives Approval in US
26 Sep 2024 //
FDA
Ajanta Pharma`s Generic Paliperidone Receives Approval in US
26 Jun 2024 //
FDA
Ascent Pharma` Generic Paliperidone Receives Approval in the U.S.
23 Aug 2023 //
FDA
J&J successfully defends against Viatris` Invega copycat
19 May 2023 //
FIERCE PHARMA
Enforcement Report - Week of March 16, 2022
17 Mar 2022 //
FDA
Health Canada Recalls Marcan Pharmaceutical`s MAR-Paliperidone Extended Release tablets
16 Nov 2021 //
HEALTH CANADA
ANI Announces Launch of Paliperidone Extended-Release Tablets
14 Jan 2020 //
PR NEWSWIRE
Inventia Healthcare`s Generic Paliperidone Receives Approval in US
12 Jun 2019 //
FDA
Alkermes says long-acting drugs help schizophrenics stay on medication longer
10 Apr 2019 //
REUTERS
Janssen`s Trevicta Receives Approval in Europe
20 Oct 2018 //
EMA
Sun Pharma’s Generic Paliperidone Receives Approval In US
11 Apr 2018 //
FDA
Invega Sustenna® (Paliperidone):Janssen Pharmaceuticals V. Teva Pharmas Usa
17 Jan 2018 //
PATENT LITIGATION
Enforcement Report - Week of July 19, 2017
19 Jul 2017 //
FDA
Teva Pharmaceuticals, USA Extends Voluntary Nationwide Recall
16 Jun 2017 //
FDA
Lawyers Investigate Invega Gynecomastia Lawsuits Against Janssen
18 Jan 2017 //
NEWSINFERNO
US FDA Enforcement Report- 18/May/2016
17 May 2016 //
FDA
FDA warns of potentially fatal skin reactions to Lilly`s Zyprexa
12 May 2016 //
FIERCE PHARMA
CHMP adopts positive opinion of Trevicta, maintenance treatment of schizophrenia
05 Apr 2016 //
EUROPEAN PHARMACEUTICAL REVIEW
Fake smiles star in Otsuka and Lundbeck`s DTC push for Rexulti in depression
10 Mar 2016 //
FIERCE PHARMA MARKETING
Otsuka stares down rival with FDA approval for Alkermes` long-acting Abilify
07 Oct 2015 //
FIERCE PHARMA
Mylan releases generic version of Invega in the U.S.
29 Sep 2015 //
NEWS MEDICAL
Allergan Launches Generic Version of INVEGA® (paliperidone)
26 Sep 2015 //
PR NEWS WIRE
Janssen`s Invega Trinza (3- Month Paliperidone Palmitate) Approved in US For Schizophrenia
20 May 2015 //
JANSSEN
Report Card: FDA Earns a Solid
25 Jan 2015 //
FDA LAW BLOG